Paclitaxel-eluting Stent Market 2027 By Type, Application | The Insight Partners

Paclitaxel-eluting Stent Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Metal Stent, Polymer Stent); Application (Peripheral Arterial Disease (PAD), Stenotic Lesions, Others)

Report Code: TIPRE00017462 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Paclitaxel-coated stents are used to treat restenotic lesions in the femoropopliteal artery. The stent work to mechanically open the obstructed vessel. Paclitaxel is released from the stent to prevent scar tissue formation in the blood vessel that can re-obstruct the artery.

MARKET DYNAMICS

The paclitaxel-eluting stent market is driving due to the increasing number if surgeries worldwide. However, lack of awareness in developing countries is expected to hamper the growth of the global paclitaxel-eluting stent market. Moreover, improving healthcare infrastructure globally is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Paclitaxel-eluting Stent Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Paclitaxel-eluting Stent market with detailed market segmentation by type, and application. The paclitaxel-eluting stent market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in paclitaxel-eluting stent market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Paclitaxel-eluting Stent market is segmented based on type, and application. Based on type, the market is segmented into metal stent, and polymer stent. Based on application, the market is segmented into peripheral arterial disease (PAD), stenotic lesions, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Paclitaxel-eluting Stent market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The paclitaxel-eluting stent market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting paclitaxel-eluting stent market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the paclitaxel-eluting stent market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the paclitaxel-eluting stent market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from paclitaxel-eluting stent market are anticipated to have lucrative growth opportunities in the future with the rising demand for paclitaxel-eluting stent market in the global market. Below mentioned is the list of few companies engaged in the Paclitaxel-eluting Stent market.
The report also includes the profiles of key players in paclitaxel-eluting stent market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   BIOTRONIK AG
  •   Boston Scientific Corporation
  •   Medtronic
  •   Opto Circuits (India) Limited
  •   Biosensors International Group, Ltd.
  •   OrbusNeich Medical Company Limited
  •   Cook Medical

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Paclitaxel-eluting Stent Market - By Type
1.3.2 Paclitaxel-eluting Stent Market - By Application
1.3.3 Paclitaxel-eluting Stent Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PACLITAXEL-ELUTING STENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. PACLITAXEL-ELUTING STENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PACLITAXEL-ELUTING STENT MARKET - GLOBAL MARKET ANALYSIS
6.1. PACLITAXEL-ELUTING STENT - GLOBAL MARKET OVERVIEW
6.2. PACLITAXEL-ELUTING STENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PACLITAXEL-ELUTING STENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. METAL STENT
7.3.1. Overview
7.3.2. Metal Stent Market Forecast and Analysis
7.4. POLYMER STENT
7.4.1. Overview
7.4.2. Polymer Stent Market Forecast and Analysis
8. PACLITAXEL-ELUTING STENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PERIPHERAL ARTERIAL DISEASE (PAD)
8.3.1. Overview
8.3.2. Peripheral Arterial Disease (PAD) Market Forecast and Analysis
8.4. STENOTIC LESIONS
8.4.1. Overview
8.4.2. Stenotic Lesions Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. PACLITAXEL-ELUTING STENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Paclitaxel-eluting Stent Market Overview
9.1.2 North America Paclitaxel-eluting Stent Market Forecasts and Analysis
9.1.3 North America Paclitaxel-eluting Stent Market Forecasts and Analysis - By Type
9.1.4 North America Paclitaxel-eluting Stent Market Forecasts and Analysis - By Application
9.1.5 North America Paclitaxel-eluting Stent Market Forecasts and Analysis - By Countries
9.1.5.1 United States Paclitaxel-eluting Stent Market
9.1.5.1.1 United States Paclitaxel-eluting Stent Market by Type
9.1.5.1.2 United States Paclitaxel-eluting Stent Market by Application
9.1.5.2 Canada Paclitaxel-eluting Stent Market
9.1.5.2.1 Canada Paclitaxel-eluting Stent Market by Type
9.1.5.2.2 Canada Paclitaxel-eluting Stent Market by Application
9.1.5.3 Mexico Paclitaxel-eluting Stent Market
9.1.5.3.1 Mexico Paclitaxel-eluting Stent Market by Type
9.1.5.3.2 Mexico Paclitaxel-eluting Stent Market by Application
9.2. EUROPE
9.2.1 Europe Paclitaxel-eluting Stent Market Overview
9.2.2 Europe Paclitaxel-eluting Stent Market Forecasts and Analysis
9.2.3 Europe Paclitaxel-eluting Stent Market Forecasts and Analysis - By Type
9.2.4 Europe Paclitaxel-eluting Stent Market Forecasts and Analysis - By Application
9.2.5 Europe Paclitaxel-eluting Stent Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Paclitaxel-eluting Stent Market
9.2.5.1.1 Germany Paclitaxel-eluting Stent Market by Type
9.2.5.1.2 Germany Paclitaxel-eluting Stent Market by Application
9.2.5.2 France Paclitaxel-eluting Stent Market
9.2.5.2.1 France Paclitaxel-eluting Stent Market by Type
9.2.5.2.2 France Paclitaxel-eluting Stent Market by Application
9.2.5.3 Italy Paclitaxel-eluting Stent Market
9.2.5.3.1 Italy Paclitaxel-eluting Stent Market by Type
9.2.5.3.2 Italy Paclitaxel-eluting Stent Market by Application
9.2.5.4 Spain Paclitaxel-eluting Stent Market
9.2.5.4.1 Spain Paclitaxel-eluting Stent Market by Type
9.2.5.4.2 Spain Paclitaxel-eluting Stent Market by Application
9.2.5.5 United Kingdom Paclitaxel-eluting Stent Market
9.2.5.5.1 United Kingdom Paclitaxel-eluting Stent Market by Type
9.2.5.5.2 United Kingdom Paclitaxel-eluting Stent Market by Application
9.2.5.6 Rest of Europe Paclitaxel-eluting Stent Market
9.2.5.6.1 Rest of Europe Paclitaxel-eluting Stent Market by Type
9.2.5.6.2 Rest of Europe Paclitaxel-eluting Stent Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Paclitaxel-eluting Stent Market Overview
9.3.2 Asia-Pacific Paclitaxel-eluting Stent Market Forecasts and Analysis
9.3.3 Asia-Pacific Paclitaxel-eluting Stent Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Paclitaxel-eluting Stent Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Paclitaxel-eluting Stent Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Paclitaxel-eluting Stent Market
9.3.5.1.1 Australia Paclitaxel-eluting Stent Market by Type
9.3.5.1.2 Australia Paclitaxel-eluting Stent Market by Application
9.3.5.2 China Paclitaxel-eluting Stent Market
9.3.5.2.1 China Paclitaxel-eluting Stent Market by Type
9.3.5.2.2 China Paclitaxel-eluting Stent Market by Application
9.3.5.3 India Paclitaxel-eluting Stent Market
9.3.5.3.1 India Paclitaxel-eluting Stent Market by Type
9.3.5.3.2 India Paclitaxel-eluting Stent Market by Application
9.3.5.4 Japan Paclitaxel-eluting Stent Market
9.3.5.4.1 Japan Paclitaxel-eluting Stent Market by Type
9.3.5.4.2 Japan Paclitaxel-eluting Stent Market by Application
9.3.5.5 South Korea Paclitaxel-eluting Stent Market
9.3.5.5.1 South Korea Paclitaxel-eluting Stent Market by Type
9.3.5.5.2 South Korea Paclitaxel-eluting Stent Market by Application
9.3.5.6 Rest of Asia-Pacific Paclitaxel-eluting Stent Market
9.3.5.6.1 Rest of Asia-Pacific Paclitaxel-eluting Stent Market by Type
9.3.5.6.2 Rest of Asia-Pacific Paclitaxel-eluting Stent Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Paclitaxel-eluting Stent Market Overview
9.4.2 Middle East and Africa Paclitaxel-eluting Stent Market Forecasts and Analysis
9.4.3 Middle East and Africa Paclitaxel-eluting Stent Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Paclitaxel-eluting Stent Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Paclitaxel-eluting Stent Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Paclitaxel-eluting Stent Market
9.4.5.1.1 South Africa Paclitaxel-eluting Stent Market by Type
9.4.5.1.2 South Africa Paclitaxel-eluting Stent Market by Application
9.4.5.2 Saudi Arabia Paclitaxel-eluting Stent Market
9.4.5.2.1 Saudi Arabia Paclitaxel-eluting Stent Market by Type
9.4.5.2.2 Saudi Arabia Paclitaxel-eluting Stent Market by Application
9.4.5.3 U.A.E Paclitaxel-eluting Stent Market
9.4.5.3.1 U.A.E Paclitaxel-eluting Stent Market by Type
9.4.5.3.2 U.A.E Paclitaxel-eluting Stent Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PACLITAXEL-ELUTING STENT MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PACLITAXEL-ELUTING STENT MARKET, KEY COMPANY PROFILES
12.1. BIOTRONIK AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOSTON SCIENTIFIC CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MEDTRONIC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. OPTO CIRCUITS (INDIA) LIMITED
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIOSENSORS INTERNATIONAL GROUP, LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ORBUSNEICH MEDICAL COMPANY LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. COOK MEDICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. BIOTRONIK AG
2. Boston Scientific Corporation
3. Medtronic
4. Opto Circuits (India) Limited
5. Biosensors International Group, Ltd.
6. OrbusNeich Medical Company Limited
7. Cook Medical
TIPRE00017462
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking